Provided by Tiger Fintech (Singapore) Pte. Ltd.

Verve Therapeutics

11.10
+0.02000.18%
Post-market: 11.150.0500+0.45%19:44 EDT
Volume:19.99M
Turnover:221.98M
Market Cap:991.46M
PE:-5.28
High:11.14
Open:11.11
Low:11.08
Close:11.08
Loading ...
May 15, 2023

Major Issues Report

Form 8-K - Current report
Mar 02, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 02, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 02, 2023

Major Issues Report

8-K - Current report
Feb 17, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 06, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 05, 2022

Major Issues Report

8-K - Current report
Nov 07, 2022

Major Issues Report

8-K - Current report
Nov 07, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2022

Major Issues Report

8-K - Current report
Aug 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 21, 2022

Major Issues Report

8-K - Current report
Jul 21, 2022

Major Issues Report

8-K - Current report
Jul 20, 2022

Major Issues Report

8-K - Current report
Jul 12, 2022

Major Issues Report

8-K - Current report